Literature DB >> 11327100

The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.

S Engeli1, A M Sharma.   

Abstract

Excessive accumulation of adipose tissue is associated with profound alterations in the cardiovascular system. including an increase in systemic blood pressure. It now appears clear that a central feature of obesity-associated hypertension is related to changes in sodium handling that may result from abnormalities in sympathetic nervous system activity, the renin-angiotensin-aldosterone system, natriuretic peptides, and kidney function. In this paper we review the role of these factors in the development of obesity-associated hypertension, thereby focusing on the potential role of adipose tissue in these alterations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11327100     DOI: 10.1007/s001090000144

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  48 in total

Review 1.  Cardiovascular consequences of obese and nonobese obstructive sleep apnea.

Authors:  Kannan Ramar; Sean M Caples
Journal:  Med Clin North Am       Date:  2010-05       Impact factor: 5.456

2.  Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.

Authors:  Alessia Buglioni; Valentina Cannone; Alessandro Cataliotti; S Jeson Sangaralingham; Denise M Heublein; Christopher G Scott; Kent R Bailey; Richard J Rodeheffer; Paolo Dessì-Fulgheri; Riccardo Sarzani; John C Burnett
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

Review 3.  Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.

Authors:  Graziela Z Kalil; William G Haynes
Journal:  Hypertens Res       Date:  2011-11-03       Impact factor: 3.872

4.  Increased incidence of diuretic use in critically ill obese patients.

Authors:  Emma J de Louw; Pepijn O Sun; Joon Lee; Mengling Feng; Roger G Mark; Leo Anthony Celi; Kenneth J Mukamal; John Danziger
Journal:  J Crit Care       Date:  2015-02-07       Impact factor: 3.425

5.  Obesity is an independent risk factor for heart failure: Zona Franca Cohort study.

Authors:  José M Baena-Díez; Alice O Byram; María Grau; Claudia Gómez-Fernández; Marc Vidal-Solsona; Gabriela Ledesma-Ulloa; Isabel González-Casafont; Javier Vasquez-Lazo; Isaac Subirana; Helmut Schroder
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

6.  High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats.

Authors:  Preethi Samuel; Quaisar Ali; Rifat Sabuhi; Yonnie Wu; Tahir Hussain
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-16

7.  Etiologies, predictors, and economic impact of readmission within 1 month among patients with takotsubo cardiomyopathy.

Authors:  Mahek Shah; Pradhum Ram; Kevin Bryan U Lo; Natee Sirinvaravong; Brijesh Patel; Byomesh Tripathi; Shantanu Patil; Vincent M Figueredo
Journal:  Clin Cardiol       Date:  2018-07-20       Impact factor: 2.882

Review 8.  Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.

Authors:  Andrew S Bomback; Philip J Klemmer
Journal:  Am J Nephrol       Date:  2009-03-20       Impact factor: 3.754

9.  Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.

Authors:  Hiroaki Masuzaki; Hiroshi Yamamoto; Christopher J Kenyon; Joel K Elmquist; Nicholas M Morton; Janice M Paterson; Hiroshi Shinyama; Matthew G F Sharp; Stewart Fleming; John J Mullins; Jonathan R Seckl; Jeffrey S Flier
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

10.  Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity.

Authors:  Andreas M Beyer; Deng-Fu Guo; Kamal Rahmouni
Journal:  J Hypertens       Date:  2013-04       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.